<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="662">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    https://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 16, 2016</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00026689</url>
  </required_header>
  <id_info>
    <org_study_id>000181</org_study_id>
    <secondary_id>00-C-0181</secondary_id>
    <nct_id>NCT00026689</nct_id>
    <nct_alias>NCT00020280</nct_alias>
  </id_info>
  <brief_title>Evaluation for NCI Radiation Oncology Branch Clinical Research Protocols</brief_title>
  <official_title>Evaluation for NCI Radiation Oncology Branch Clinical Research Protocols</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Cancer Institute (NCI)</agency>
      <agency_class>NIH</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Institutes of Health Clinical Center (CC)</source>
  <oversight_info>
    <authority>United States: Federal Government</authority>
  </oversight_info>
  <brief_summary>
    <textblock>
      Background:

      -This protocol will provide a means for screening potential candidates for NCI Radiation
      Oncology Branch (ROB) protocols.

      Objectives:

      -To permit evaluation of patients referred to the NCI Radiation Oncology Branch in order to
      identify individuals who will be suitable candidates for Radiation Oncology Branch clinical
      research protocols.

      Eligibility:

      -Patients suspected of having, or with biopsy proven malignant disease or patients with a
      benign condition for whom radiotherapy is a potential treatment.

      Design:

      -This is a screening protocol. No investigational treatments will be administered on this
      protocol.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Background:

      -This protocol will provide a means for screening potential candidates for NCI Radiation
      Oncology Branch (ROB) protocols.

      Objectives:

      -To permit evaluation of patients referred to the NCI Radiation Oncology Branch in order to
      identify individuals who will be suitable candidates for Radiation Oncology Branch clinical
      research protocols.

      Eligibility:

      -Patients suspected of having, or with biopsy proven malignant disease or patients with a
      benign condition for whom radiotherapy is a potential treatment.

      Design:

      -This is a screening protocol. No investigational treatments will be administered on this
      protocol.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>July 2000</start_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Time Perspective: Cross-Sectional</study_design>
  <primary_outcome>
    <measure>To permit evaluation of patients referred to the NCI Radiation Oncology Branch in order to identify individuals who will be suitable candidates for Radiation Oncology Branch clinical research protocols.</measure>
    <time_frame>Completion of study</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <enrollment type="Anticipated">1000</enrollment>
  <condition>Prostate</condition>
  <condition>Brain</condition>
  <condition>Breast</condition>
  <condition>Lung</condition>
  <condition>Endometrial</condition>
  <eligibility>
    <criteria>
      <textblock>
        -  INCLUSION CRITERIA:

        Patients suspected of having, or with biopsy proven malignant disease or patients with a
        benign condition for whom radiotherapy is a potential treatment.

        Patient or guardian is able to provide informed consent.

        EXCLUSION CRITERIA:

        Candidates who do not meet the inclusion criteria.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kevin A Camphausen, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>National Cancer Institute (NCI)</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Theresa Cooley-Zgela, R.N.</last_name>
    <phone>(301) 451-8905</phone>
    <email>theresa.cooleyzgela@nih.gov</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Kevin A Camphausen, M.D.</last_name>
    <phone>(301) 496-5457</phone>
    <email>camphauk@mail.nih.gov</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>National Institutes of Health Clinical Center, 9000 Rockville Pike</name>
      <address>
        <city>Bethesda</city>
        <state>Maryland</state>
        <zip>20892</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>For more information at the NIH Clinical Center contact National Cancer Institute Referral Office</last_name>
      <phone>(888) NCI-1937</phone>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://clinicalstudies.info.nih.gov/cgi/detail.cgi?A_2000-C-0181.html</url>
    <description>NIH Clinical Center Detailed Web Page</description>
  </link>
  <verification_date>March 2016</verification_date>
  <lastchanged_date>May 11, 2016</lastchanged_date>
  <firstreceived_date>November 14, 2001</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Evaluation</keyword>
  <keyword>Screening</keyword>
  <keyword>Cancer</keyword>
  <keyword>Radiation</keyword>
  <keyword>Eligibility</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
